Sabril 500 mg Tablets contain vigabatrin, an antiepileptic medicine that increases the availability of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. It is prescribed for specific seizure disorders when other treatments have not provided adequate control or when it is appropriate under the relevant product authorization.
Depending on the country-specific product labeling, Sabril may be used alongside other antiepileptic medicines for treatment-resistant partial seizures and as monotherapy for infantile spasms (West syndrome).
Vigabatrin requires specialist supervision because it can cause serious and potentially permanent damage to vision.
Sabril 500 mg Tablets may be prescribed for:
The exact approved indications and eligible patient groups vary by country. Treatment suitability must be determined by a specialist.
Take Sabril 500 mg Tablets exactly as prescribed by a specialist. The dose and treatment schedule depend on the patient’s age, diagnosis, response to treatment, kidney function and other clinical factors.
Swallow or administer the medicine according to the official product instructions. Do not change the dose, stop treatment suddenly or use it for another condition without medical guidance.
Regular specialist reviews are required to evaluate treatment effectiveness, ongoing need and adverse effects.
Possible adverse effects include:
Vision loss is a major safety concern. Vigabatrin can cause progressive, potentially permanent visual-field loss. Vision damage may occur even when the patient does not notice symptoms. Baseline and regular vision assessments are essential during treatment and as advised after treatment ends.
Seek medical advice promptly for new visual symptoms, unusual behaviour, significant mood changes or worsening seizures. Severe or sudden symptoms require urgent assessment.
Sabril should be initiated and monitored by an appropriate specialist. Before treatment, inform the healthcare professional about existing visual problems, kidney disease, mental health history and all current medicines.
Important precautions include:
Treatment should be continued only when its expected benefits justify the risks and when ongoing monitoring can be maintained.
Store Sabril according to the product packaging and official patient information leaflet. Keep tablets in their original packaging where appropriate, away from children, and do not use them after the expiry date.
For Sabril 500 mg tablet pricing, pack sizes and availability, contact the supplier to verify the exact product, manufacturer, current stock and supporting documentation.
Product authorization, dispensing requirements and import eligibility differ by country. Confirm local regulations and obtain the medicine through an authorized pharmacy or eligible supplier.
This description is for general product information and does not replace professional medical advice, diagnosis or treatment. Sabril contains vigabatrin and requires specialist supervision because of the risk of potentially permanent vision loss. Always consult the official product leaflet and treating specialist for complete indications, dosage instructions, contraindications and monitoring requirements.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.